Citations

Mayo Clinic

Showing 10 of 108599 citations.

Automated T‐wave analysis can differentiate acquired QT prolongation from congenital long QT syndrome
Sugrue, Alan , Křemen, Václav , Bos, J. Martijn , Qiang, Bo , Rohatgi, Ram K., Sapir, Yehu , Brady, Peter A. , Asirvatham, Samuel J. , Friedman, Paul A. , Ackerman, Michael J. , Caraballo, Pedro J. , Noseworthy, Peter A. , Attia, Zachi I. , Asirvatham, Samuel J , Kremen, Vaclav , Bos, Johan M

Annals of Noninvasive Electrocardiology | April 21, 2017 | Volume: 22 | Issue: 6 | Pages: No page available

10.1111/anec.12455 | PMID 28429460 Get It

BackgroundProlongation of the QT on the surface electrocardiogram can be due to either genetic or acquired causes. Distinguishing congenital long QT syndrome (LQTS) from acquired QT prolongation has important prognostic and management implications. We aimed to investigate if quantitative T‐wave analysis could provide a tool for the physician to differentiate between congenital and acquired QT prolongation.MethodsPatients were identified through an institution‐wide computer‐based QT screening system which alerts the physician if the QTc ≥ 500 ms. ECGs were retrospectively analyzed with an automated T‐wave analysis program. Congenital LQTS was compared in a 1:3 ratio to those with an identified acquired etiology for QT prolongation (electrolyte abnormality and/or prescription of known QT prolongation medications). Linear discriminant analysis was performed using 10‐fold cross‐validation to statistically test the selected features.ResultsThe 12‐lead ECG of 38 patients with congenital LQTS and 114 patients with drug‐induced and/or electrolyte‐mediated QT prolongation were analyzed. In lead V5, patients with acquired QT prolongation had a shallower T wave right slope (−2,322 vs. −3,593 mV/s), greater T‐peak‐Tend interval (109 vs. 92 ms), and smaller T wave center of gravity on the x axis (290 ms vs. 310 ms; p < .001). These features could distinguish congenital from acquired causes in 77% of cases (sensitivity 90%, specificity 58%).ConclusionT‐wave morphological analysis on lead V5 of the surface ECG could successfully differentiate congenital from acquired causes of QT prolongation.
Consensus Statement on Inpatient Use of Continuous Glucose Monitoring
Wallia, Amisha , Rushakoff, Robert J , Klonoff, David C. , Rubin, Daniel J. , Thompson, Bithika , Cook, Curtiss B. , Umpierrez, Guillermo E. , Golden, Sherita Hill

Journal of Diabetes Science and Technology | April 21, 2017 | Volume: 11 | Issue: 5 | Pages: 1036-1044

10.1177/1932296817706151 | PMID 28429611 Get It

In June 2016, Diabetes Technology Society convened a panel of US experts in inpatient diabetes management to discuss the current and potential role of continuous glucose monitoring (CGM) in the hospital. This discussion combined with a literature review was a follow-up to a meeting, which took place in May 2015. The panel reviewed evidence on use of CGM in 3 potential inpatient scenarios: (1) the intensive care unit (ICU), (2) non-ICU, and (3) transitioning outpatient CGM use into the hospital setting. Panel members agreed that data from limited studies and theoretical considerations suggested that use of CGM in the hospital had the potential to improve patient clinical outcomes, and in particular reduction of hypoglycemia. Panel members discussed barriers to widespread adoption of CGM, which patients would benefit most from use of this technology, and what type of outcome studies are needed to guide use of CGM in the inpatient setting.
Perioperative Outcomes of Robotic-Assisted Hysterectomy Compared With Open Hysterectomy
Gali, Bhargavi , Plevak, David J., Schroeder, Darrell R. , Wilson, Timothy O., Jankowski, Christopher J., Schroeder, Darrell, Bakkum‐Gamez, Jamie N. , Schroeder, Darrell

Anesthesia & Analgesia | April 21, 2017 | Volume: 126 | Issue: 1 | Pages: 127-133

10.1213/ane.0000000000001935 | PMID 28430689 Get It

BACKGROUND: Increasing numbers of robotic hysterectomies (RH) are being performed. To provide ventilation (with pneumoperitoneum and steep Trendelenburg position) for these procedures, utilization of lung protective strategies with limiting airway pressures and tidal volumes is difficult. Little is known about the effects of intraoperative mechanical ventilation and high peak airway pressures on perioperative complications. We performed a retrospective review to determine whether patients undergoing RH had increased pulmonary complications compared to total abdominal hysterectomy (TAH). METHODS: We performed a single center retrospective review comparing the intraoperative, anesthetic, and immediate and 30-day postoperative course of patients undergoing RH to TAH, including intraoperative ventilatory parameters and respiratory complications. Patients undergoing TAH (201) from 2004 to 2006 were compared to RH (251) from 2009 to 2012. It was our hypothesis that patients undergoing RH would have increased incidence of postoperative pulmonary complications. A secondary hypothesis was that morbid obesity predicts pulmonary complications in patients undergoing RH. Complications were compared between groups using Fisher’s exact test. To account for potential confounders, the primary analysis was performed for a subgroup of patients matched on the propensity for RH. RESULTS: A total of 351 RH and 201 TAH procedures are included. Higher inspiratory pressures were required in ventilation of the RH group (median [25th, 75th] 31 [26, 36] cm H 2 O) than the TAH group (23 [19, 27] cm H 2 O) ( P < .001) at 30 minutes after incision. Peak inspiratory pressures at 30 minutes after incision for RH increased according to increasing body mass index group ( P < .001). There were 163 RH and 163 TAH procedures included in the propensity matched analysis. From this analysis, there were no significant differences in cardiopulmonary complications between RH and TAH (0.6% vs 1.2%; odds ratio = 2.0, 95% confidence interval = 0.2–2.4; P = 1.00). Surgical site infection was significantly lower in the RH compared to TAH group (0.6% vs 8.6%; P < .001). Hospital length of stay was longer for those who underwent TAH versus RH (median [25th, 75th] 2 [2, 3] vs 1 [0, 2] days; P < .001). CONCLUSIONS: There was no significant difference in perioperative complications in obese and morbidly obese women compared to nonobese undergoing RH. Patients undergoing RH had shorter hospital stays, fewer infectious complications, and no increase in overall complications compared to TAH. Higher ventilatory airway pressures (RH versus TAH and obese versus nonobese) did not result in an increase in cardiopulmonary or overall complications. We believe that peritoneal insufflation attenuates the effect of high airway pressures by raising intrapleural pressure and reducing the gradient across terminal bronchioles and alveoli. Thus, we propose that lung protective strategies for patients undergoing RH account for the markedly elevated intraperitoneal and intrapleural pressures, whereas transpulmonary airway pressures remain static. This reduced transpulmonary gradient attenuates the strain on lung tissue that would otherwise be imposed by ventilation at high pressures.
Acute on chronic liver failure
Kamath, Patrick S.

Clinical Liver Disease | April 21, 2017 | Volume: 9 | Issue: 4 | Pages: 86-88

10.1002/cld.625 | PMID 30992966 Get It

The Role of Minimal Residual Disease Testing in Myeloma Treatment Selection and Drug Development: Current Value and Future Applications
Auclair, Daniel , Kelloff, Gary J. , Sigman, Caroline C. , Avet‐Loiseau, Hervé , Farrell, Ann T. , Gormley, Nicole , Kumar, Shaji , Munshi, Nikhil C. , Cavo, Michèle , Davies, Faith E. , Bacco, Alessandra Di , Dickey, Jennifer S., Gutman, Steven, Higley, Howard R., Hussein, Mohamad A., Jessup, J. Milburn , Little, Richard F. , Loberg, Robert D., Lohr, Jens G. , Mukundan, Lata , Omel, James, Pugh, Trevor J. , Reaman, Gregory H. , Robbins, Michael , Sasser, A. Kate, Valente, Nancy, Zamagni, Elena , Anderson, Kenneth C. , Landgren, Ola , Kirsch, Ilan R. , Pugh, Trevor J , Davies, Faith E , Gormley, Nicole , Zamagni, Elena

Clinical Cancer Research | April 20, 2017 | Volume: 23 | Issue: 15 | Pages: 3980-3993

10.1158/1078-0432.ccr-16-2895 | PMID 28428191 Get It

Abstract Treatment of myeloma has benefited from the introduction of more effective and better tolerated agents, improvements in supportive care, better understanding of disease biology, revision of diagnostic criteria, and new sensitive and specific tools for disease prognostication and management. Assessment of minimal residual disease (MRD) in response to therapy is one of these tools, as longer progression-free survival (PFS) is seen consistently among patients who have achieved MRD negativity. Current therapies lead to unprecedented frequency and depth of response, and next-generation flow and sequencing methods to measure MRD in bone marrow are in use and being developed with sensitivities in the range of 10−5 to 10−6 cells. These technologies may be combined with functional imaging to detect MRD outside of bone marrow. Moreover, immune profiling methods are being developed to better understand the immune environment in myeloma and response to immunomodulatory agents while methods for molecular profiling of myeloma cells and circulating DNA in blood are also emerging. With the continued development and standardization of these methodologies, MRD has high potential for use in gaining new drug approvals in myeloma. The FDA has outlined two pathways by which MRD could be qualified as a surrogate endpoint for clinical studies directed at obtaining accelerated approval for new myeloma drugs. Most importantly, better understanding of MRD should also contribute to better treatment monitoring. Potentially, MRD status could be used as a prognostic factor for making treatment decisions and for informing timing of therapeutic interventions. Clin Cancer Res; 23(15); 3980–93. ©2017 AACR.
In Reply
Apple, Fred S. , Sandoval, Yader , Jaffe, Allan S. , Jaffe, Allan S.

Clinical Chemistry | April 20, 2017 | Volume: 63 | Issue: 6 | Pages: 1167-1170

10.1373/clinchem.2017.273250 | PMID 28428359 Get It

Effect of Repeat Measurements of High-Sensitivity Cardiac Troponin on the Same Sample Using the European Society of Cardiology 0-Hour/1-Hour or 2-Hour Algorithms for Early Rule-Out and Rule-In for Myocardial Infarction
Kavsak, Peter A. , Clark, Lorna , Jaffe, Allan S. , Jaffe, Allan S. , Kavsak, Peter

Clinical Chemistry | April 20, 2017 | Volume: 63 | Issue: 6 | Pages: 1163-1165

10.1373/clinchem.2017.272914 | PMID 28428358 Get It

The MicroRNA-199a/214 Cluster Targets E-Cadherin and Claudin-2 and Promotes High Glucose-Induced Peritoneal Fibrosis
Che, Ming-wen, Shi, Tiantian , Feng, Shidong, Li, Huan , Feng, Ning , Lou, Weijuan , Dou, Jianhua, Tang, Guangbo , Huang, Chen , Xu, Guoshuang , Qian, Qi , Sun, Shiren , He, Lijie , Wang, Hanmin , He, Lijie , Zhang, Xiaomin

Journal of the American Society of Nephrology | April 20, 2017 | Volume: 28 | Issue: 8 | Pages: 2459-2471

10.1681/asn.2016060663 | PMID 28428333 Get It

Serum response factor (SRF) was found to be involved in the phenotypic transition and fibrosis of the peritoneal membrane during treatment with peritoneal dialysis (PD), but the exact mechanism remains unclear. SRF regulates microRNAs (miRNAs) that contain the SRF-binding consensus (CArG) element in the promoter region. Therefore, we investigated whether the miR-199a/214 gene cluster, which contains a CArG element in its promoter, is directly regulated by SRF. High-glucose (HG) treatment significantly unregulated the expression of the miR-199a-5p/214–3p gene cluster in human peritoneal mesothelial cells (HPMCs). By chromatin immunoprecipitation and reporter assays, we found that SRF binds to the miR-199a-5p/214–3p gene cluster promoter after HG stimulation. In vitro , in HPMCs, silencing of miR-199a-5p or miR-214–3p inhibited the HG-induced phenotypic transition and cell migration but enhanced cell adhesion, whereas ectopic expression of mimic oligonucleotides had the opposite effects. Both miR-199a-5p and miR-214–3p targeted claudin-2 and E-cadherin mRNAs. In a PD rat model, treatment with an SRF inhibitor silenced miR-199a-5p and miR-214–3p and alleviated HG-PD fluid–induced damage and fibrosis. Overall, this study reveals a novel SRF–miR-199a/miR-214–E-cadherin/claudin-2 axis that mediates damage and fibrosis in PD.
Opioid Use in Patients with Congestive Heart Failure
Dawson, Nancy L. , Roth, Victoria, Hodge, David O. , Vargas, Emily , Burton, M. Caroline , Brennan, Emily , Vargas, Emily R

Pain Medicine | April 20, 2017 | Volume: 19 | Issue: 3 | Pages: 485-490

10.1093/pm/pnx103 | PMID 28460060 Get It

Global position paper on cardiovascular regenerative medicine
Fernández‐Avilés, Francisco , Sanz‐Ruiz, Ricardo , Climent, Andreu M. , Badimón, Lina , Charron, Dominique , Fuster, Valentı́n , Janssens, Stefan , Kim, Hyo‐Soo , Lüscher, Thomas F. , Martin, John F. , Menasché, Philippe , Simari, Robert D., Stone, Gregg W. , Willerson, James T., Group, the TACTICS (Transnational Alliance for Regenerative Therapies in Cardiovascular Syndromes) Writing, Chairpersons:, Authors/Task Force Members., Broughton, Kathleen M., DiFede, Darcy L., Madonna, Rosalinda , Penn, Marc S. , Sussman, Mark A. , Wollert, Kai C. , Chamuleau, Steven A. J. , Fernández‐Santos, María Eugenia , Goliasch, Georg , Gyöngyösi, Mariann , Hare, Joshua M. , Tompkins, Bryon A. , Winkler, Johannes , Bayés‐Genís, Antoni , Henry, Timothy D. , Taylor, Doris A. , Pelacho, Beatriz , Prósper, Felipe , Perin, Emerson C. , Pompilio, Giulio , Duckers, Eric, Losordo, Douglas W. , Sánchez, Pedro L. , Sherman, Warren, Wojakowski, Wojtek, Zeiher, Andreas M. , Kastrup, Jens, Mathur, Anthony , Amario, Domenico, Povsic, Thomas J. , Bolli, Roberto , Kastrup, Jens , Terzic, André , Wu, Joseph C. , Group, the TACTICS (Transnational Alliance for Regenerative Therapies in Cardiovascular Syndromes) Writing, Chairpersons:, Authors/Task Force Members., Dimmeler, Stefanie , Sluijter, Joost P G , Balkan, Wayne , Lerman, Amir , Gersh, Bernard J. , Bartúnek, Jozef , Ferdinandy, Péter , Wojakowski, Wojtek, Kastrup, Jens, Roncalli, Jerome G. , Crea, Filippo , D’Amario, Domenico , Traverse, Jay H. , Ylä-Herttuala, Seppo , Gyöngyösi, Mariann , Madonna, Rosalinda , Prosper, Felipe

European Heart Journal | April 20, 2017 | Volume: 38 | Issue: 33 | Pages: 2532-2546

10.1093/eurheartj/ehx248 | PMID 28575280 Get It